When my daughter was diagnosed with celiac disease, a well-meaning relative asked whether we had tested the whole family. I hadn't. That question sent me into research mode, and what I found changed how I think about genetic risk in general.

The test checks two gene variants, not the disease

Celiac genetic testing looks for two human leukocyte antigen variants called HLA-DQ2 and HLA-DQ8. These proteins sit on the surface of certain immune cells and help those cells recognize pieces of gluten when gluten makes its way into the digestive tract. Researchers who study diagnosed cases find DQ2 in 90 to 95 percent of people with celiac disease. DQ8 accounts for most of the remaining cases. If a person lacks both variants, celiac disease drops off the list of likely explanations for their symptoms.

A positive result tells you almost nothing on its own. Population studies estimate that 30 to 40 percent of people carry DQ2 or DQ8. That means millions of people carry one of these variants and never develop the disease. Only about 1 percent of people get celiac disease. The genes are necessary, but they are not the trigger. Gluten exposure has to happen, and something else, still not fully understood, has to turn the immune system against the lining of the small intestine.

How family clusters led to HLA typing

Doctors have known for a long time that celiac disease runs in families. Family studies report first-degree relative risk at 5 to 10 percent, well above the 1 percent baseline. Pinning down the specific genetic link took decades.

In the 1970s, researchers noticed an association between celiac disease and a genetic marker called HLA-B8. That was the first time anyone could point to a specific genetic region connected to the disease. Over the 1980s, researchers confirmed the stronger association sat with DQ2, a nearby genetic region, and later identified DQ8 as a second contributor. Today the test marketed to families checks directly for both variants and reports a simple yes or no.

Learning that timeline cleared up a common misunderstanding for me. A positive celiac gene test does not work like the test for Huntington's disease, where carrying the gene means the condition will almost certainly develop. DQ2 and DQ8 are susceptibility markers, not disease genes.

The gap between carrying the gene and developing the disease

The numbers were the part that surprised me most. Researchers estimate that more than a third of people in the United States carry at least one of the celiac-associated HLA variants. Confirmed celiac disease affects about 1 percent of the population, and many cases go undiagnosed. Even if every undiagnosed case were counted, the total would not come close to the share of people who carry the genes.

Out of 100 people who all carry DQ2, roughly 1 will ever develop celiac disease. The other 99 will not.

What a negative result rules out

A negative result is the useful one. If a family member tests negative for both DQ2 and DQ8, celiac disease becomes unlikely as an explanation for their symptoms. Screening studies report the negative predictive value near 99 percent. That means a negative result rules celiac out, which can spare someone from further testing and from the anxiety of wondering.

When a family member tests negative for both markers, that person can usually stop the annual antibody screening and move on without questioning every stomachache. With a positive result, your family moves into watching mode: track symptoms, stay on the antibody screening schedule, and let the care team decide when additional testing is warranted. A negative result lets someone exhale. A positive result means the family keeps watching.

At-home kits made the confusion worse

Over the past fifteen years, millions of people have received risk reports from direct-to-consumer genetic kits. Someone who learns they carry DQ2 can walk away believing they have a high chance of getting celiac disease. The reports usually explain the real numbers in the fine print, but the first page leaves an impression the fine print cannot undo.

People have learned to read risk markers as verdicts. The same pattern plays out for other common conditions with polygenic risk scores. The data from these kits is real. People still read the risk as a verdict because the report design encourages it.

What we do at our house

After my daughter's diagnosis, understanding the limits of genetic testing changed how we managed our kitchen. This test does not show which family members will develop celiac disease, and it does not show when. What it can do is narrow the watch list.

That is also part of why our kitchen leans so heavily on meals that work for everyone. When one child has celiac and another does not, dinner goes more smoothly when the food is gluten-free by default and good enough that nobody asks for a second option. We built Clean Monday Meals around that idea: food that is safe for the family member with celiac and still welcomed by the ones who could eat anything.

Practical takeaways for families considering testing

Genetic testing for celiac disease is a screening tool with limits. Here is what the results mean for a family:

• Positive result: a susceptibility marker, not a diagnosis and not a prediction.
• Negative result: clears celiac disease as a likely cause.
• The test cannot tell you when symptoms will start, how severe they will be, or whether they will ever appear.
• Talk to your pediatrician or a gastroenterologist before you make decisions from any genetic test result.

If you are considering testing your kids after a celiac diagnosis in the family, talk to your pediatrician or a gastroenterologist about what the results can and cannot tell you. The test is most useful for the one question it answers well: who can stop worrying, and who should keep watching.

If you are looking for gluten-free meals that make the watching easier, our free Recipe App has hundreds of family-tested dinners at cleanmondaymeals.com. Make it, and tag us @cleanmondaymeals.